Department of Surgery (Urology), Aga Khan University, Stadium Road, P O Box 3500, Karachi, Pakistan.
Department of Nephrology, Birmingham Children's Hospital NHS Foundation Trust, Steelhouse Lane, Birmingham, B4 6 NH, UK.
Urolithiasis. 2018 Apr;46(2):187-195. doi: 10.1007/s00240-017-0996-8. Epub 2017 Jun 28.
Primary hyperoxalurias (PH) are devastating, autosomal recessive diseases causing renal stones. Undifferentiated hyperoxaluria is seen in up to 43% of Pakistani paediatric stone patients. High rates of consanguinity in Pakistan suggest significant local prevalence. There is no detailed information regarding number of cases, clinical features, and genetics in Pakistan-origin (P-o) patients. We reviewed available information on P-o PH patients recorded in the literature as well as from two major PH registries (the Rare Kidney Stone Consortium PH Registry (RKSCPHR) and the OxalEurope PH Registry (OxER); and the Aga Khan University Hospital in Pakistan. After excluding overlaps, we noted 217 P-o PH subjects (42 in OxER and 4 in RKSCPHR). Presentations were protean. Details of mutations were available for 94 patients of 201 who had genetic analyses. Unique mutations were noted. Mutation [c.508G>A (p. Gly170Arg)] (present in up to 25% in the West) was reported in only one case. In one series, only 30% had mutations on exons 1,4,7 of AGXT. Of 42 P-o patients in OxER, 52.4% were PH1, 45.2% PH2, and 2.4% PH3. Of concern is that diagnosis was made after renal transplant rejection (four cases) and on bone-marrow aspiration (in five). Lack of consideration of PH as a diagnosis, late diagnosis, and loss of transplanted kidneys mandates that PH be searched for diligently. Mutation analysis will need to extend to all exons and include PH 1,2,3. There is a need to spread awareness and identify patients through a scoring or screening system that alerts physicians to consider a diagnosis of PH.
原发性高草酸尿症 (PH) 是一种破坏性的常染色体隐性遗传病,可导致肾结石。在多达 43%的巴基斯坦儿科结石患者中可见未分化高草酸尿症。巴基斯坦近亲结婚率高,表明其局部患病率较高。目前尚无关于巴基斯坦裔(P-o)患者病例数量、临床特征和遗传学的详细信息。我们查阅了文献中记录的 P-o PH 患者以及两个主要 PH 登记处(罕见肾结石联盟 PH 登记处(RKSCPHR)和 OxalEurope PH 登记处(OxER)以及巴基斯坦 Aga Khan 大学医院的可用信息。排除重叠后,我们注意到 217 名 P-o PH 患者(42 名在 OxER,4 名在 RKSCPHR)。临床表现多样。对有基因分析的 201 名患者中的 94 名患者的突变细节进行了评估。注意到了独特的突变。突变 [c.508G>A (p. Gly170Arg)](在西方高达 25%的患者中存在)仅在一个病例中报道过。在一个系列中,只有 30%的患者在 AGXT 的外显子 1、4、7 上有突变。OxER 中的 42 名 P-o 患者中,52.4%为 PH1,45.2%为 PH2,2.4%为 PH3。值得关注的是,有 4 例是在肾移植排斥后,5 例是在骨髓抽吸后才做出 PH 的诊断。由于没有考虑将 PH 作为一种诊断,诊断较晚,以及移植肾脏丢失,因此需要积极寻找 PH。突变分析需要扩展到所有外显子,包括 PH1、2、3。需要通过评分或筛查系统来提高认识并识别患者,该系统可提醒医生考虑 PH 的诊断。